These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2862572

  • 21. [Treatment of spasticity by intrathecal baclofen treatment].
    Helén P, Kuurne T.
    Duodecim; 1993; 109(14):1251-5. PubMed ID: 8062701
    [No Abstract] [Full Text] [Related]

  • 22. Drug delivery to the brain by central infusion: clinical application in patients with Alzheimer's disease.
    Harbaugh RE.
    Int Clin Psychopharmacol; 1986 Jan; 1(1):77-83. PubMed ID: 2881962
    [No Abstract] [Full Text] [Related]

  • 23. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
    Kofler M, Quirbach E, Schauer R, Singer M, Saltuari L.
    Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
    [Abstract] [Full Text] [Related]

  • 24. [Spasticity treatment with spinal morphine or midazolam. In vitro experiments, animal studies and clinical studies on compatibility and effectiveness].
    Müller H, Gerlach H, Boldt J, Börner U, Hild P, Oehler KU, Zierski J, Hempelmann G.
    Anaesthesist; 1986 May; 35(5):306-16. PubMed ID: 2943190
    [Abstract] [Full Text] [Related]

  • 25. Intraventricular bethanechol in Alzheimer's disease: a continuing controversy.
    Whitehouse PJ.
    Neurology; 1988 Feb; 38(2):307-8. PubMed ID: 2893315
    [No Abstract] [Full Text] [Related]

  • 26. [Intraventricular morphine administration as a treatment possibility for patients with intractable pain].
    Seiwald M, Alesch F, Kofler A.
    Wien Klin Wochenschr; 1996 Feb; 108(1):5-8. PubMed ID: 8677660
    [Abstract] [Full Text] [Related]

  • 27. [Implantable continuous epidural morphine infusion system for relief of chronic cancer pain].
    Moritake K, Handa H, Umeda S, Nishioka T, Suwa H, Konishi T, Takaya M.
    No Shinkei Geka; 1986 May; 14(6):761-8. PubMed ID: 3748284
    [Abstract] [Full Text] [Related]

  • 28. [Relief of cancer pain by daily epidural injections of morphine using an implanted subcutaneous device].
    Bunodière M, Colbert N, Renaud J.
    Ann Fr Anesth Reanim; 1984 May; 3(2):129-30. PubMed ID: 6711919
    [Abstract] [Full Text] [Related]

  • 29. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.
    Harbaugh RE, Roberts DW, Coombs DW, Saunders RL, Reeder TM.
    Neurosurgery; 1984 Oct; 15(4):514-8. PubMed ID: 6149490
    [Abstract] [Full Text] [Related]

  • 30. Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain.
    Brennan PM, Whittle IR.
    Br J Neurosurg; 2008 Aug; 22(4):508-19. PubMed ID: 18649160
    [Abstract] [Full Text] [Related]

  • 31. [Comparison of morphine analgesia by peridural, subarachnoid and intracerebroventricular injections].
    Batier C, Blanchet P, Benezech J, Roquefeuil B.
    Cah Anesthesiol; 1985 Aug; 33(1):43-5. PubMed ID: 3838915
    [No Abstract] [Full Text] [Related]

  • 32. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study.
    Harbaugh RE, Reeder TM, Senter HJ, Knopman DS, Baskin DS, Pirozzolo F, Chui HC, Shetter AG, Bakay RA, Leblanc R.
    J Neurosurg; 1989 Oct; 71(4):481-6. PubMed ID: 2571689
    [Abstract] [Full Text] [Related]

  • 33. Chronic intrathecal baclofen in severely disabling spasticity: selection, clinical assessment and long-term benefit.
    Pirotte B, Heilporn A, Joffroy A, Zegers de Beyl D, Wesel P, Brotchi J, Levivier M.
    Acta Neurol Belg; 1995 Dec; 95(4):216-25. PubMed ID: 8553795
    [Abstract] [Full Text] [Related]

  • 34. Medical marijuana: emerging applications for the management of neurologic disorders.
    Carter GT, Ugalde V.
    Phys Med Rehabil Clin N Am; 2004 Nov; 15(4):943-54, ix. PubMed ID: 15458761
    [Abstract] [Full Text] [Related]

  • 35. Continuous pain relief.
    Finch M.
    Nurs Times; 2004 Nov; 85(30):30-1. PubMed ID: 2771733
    [No Abstract] [Full Text] [Related]

  • 36. Managing spasticity with intrathecal drug delivery.
    Barker E.
    RN; 2008 Apr; 71(4):24-9; quiz 30. PubMed ID: 18524352
    [No Abstract] [Full Text] [Related]

  • 37. Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease.
    Fox JH, Bennett DA, Goetz CG, Penn RD, Savoy S, Clasen R, Wilson RS.
    Neurology; 1989 Sep; 39(9):1265. PubMed ID: 2570380
    [No Abstract] [Full Text] [Related]

  • 38. Intracerebroventricular bethanechol for Alzheimer's disease. Variable dose-related responses.
    Read SL, Frazee J, Shapira J, Smith C, Cummings JL, Tomiyasu U.
    Arch Neurol; 1990 Sep; 47(9):1025-30. PubMed ID: 1975738
    [Abstract] [Full Text] [Related]

  • 39. [Current therapeutic possibilities in neurology].
    Uldry PA.
    Rev Med Suisse Romande; 1992 Jul; 112(7):629-34. PubMed ID: 1496214
    [No Abstract] [Full Text] [Related]

  • 40. The necessity of human trials of putative therapies for Alzheimer's disease.
    Knopman D.
    Neurobiol Aging; 1989 Jul; 10(5):633-4; discussion 648-50. PubMed ID: 2572987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.